UNSPSC 51161700: Drugs used for respiratory tract disorders

This classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.

UNSPSC 51161700 Drugs used for respiratory tract disorders is a Class code that encompasses emergency and public-health pharmaceuticals, including naloxone (opioid reversal agents) and related drug-management systems procured by county health departments and community health programs. State and local governments buy naloxone for overdose-response initiatives, often paired with safe drug deactivation or disposal systems, and deploy these supplies through county health buildings, emergency services networks, and community-based health facilities. The procurement typically follows competitive bidding (IFB) processes with quarterly or regular delivery schedules, fixed pricing per unit, and standard compliance requirements including E-Verify, drug-free workplace certification, and insurance coverage (workers' compensation, general liability, professional liability). Vendors absorb shipping and delivery costs in their proposals.

Seminole County, Florida posted one recent tracked opportunity under this code: IFB 60459723LAS, released June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The contract structure includes a two-year initial term with a one-year renewal option and a three-month probationary termination clause. The solicitation notes potential FEMA funding, which triggers federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. The source shows limited recent activity — a single Florida county procurement — and does not surface broader geographic spread or activity from other state or local issuing bodies under this code.